GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Net Margin %
中文

Reunion Neuroscience (TSX:REUN) Net Margin % : 0.00% (As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Reunion Neuroscience's Net Income for the three months ended in Mar. 2023 was C$-6.49 Mil. Reunion Neuroscience's Revenue for the three months ended in Mar. 2023 was C$0.00 Mil. Therefore, Reunion Neuroscience's net margin for the quarter that ended in Mar. 2023 was 0.00%.

The historical rank and industry rank for Reunion Neuroscience's Net Margin % or its related term are showing as below:


TSX:REUN's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -163.08
* Ranked among companies with meaningful Net Margin % only.

Reunion Neuroscience Net Margin % Historical Data

The historical data trend for Reunion Neuroscience's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Net Margin % Chart

Reunion Neuroscience Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Net Margin %
-262,800.00 -2,405.62 - -

Reunion Neuroscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Reunion Neuroscience's Net Margin %

For the Biotechnology subindustry, Reunion Neuroscience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reunion Neuroscience's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reunion Neuroscience's Net Margin % distribution charts can be found below:

* The bar in red indicates where Reunion Neuroscience's Net Margin % falls into.



Reunion Neuroscience Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Reunion Neuroscience's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-48.493/0
= %

Reunion Neuroscience's Net Margin for the quarter that ended in Mar. 2023 is calculated as

Net Margin=Net Income (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-6.492/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Reunion Neuroscience  (TSX:REUN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Reunion Neuroscience Net Margin % Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Reunion Neuroscience (TSX:REUN) Business Description

Traded in Other Exchanges
N/A
Address
30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3
Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.

Reunion Neuroscience (TSX:REUN) Headlines

No Headlines